FDA Inspection 980981 — Huijian Wang, MD

Huijian Wang, MD — FEI 3012286005

The FDA completed an inspection of Huijian Wang, MD on Jul 19, 2016 in Daytona Beach, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 19, 2016
Fiscal Year
2016
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Daytona Beach, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
296821 CFR 812.100Investigator non-compliance with agreement/plan/regulations